tiprankstipranks
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market
MIST
Milestone Pharmaceuticals
RESEARCH TOOLSreports
Want to see MIST full AI Analyst Report?

Milestone Pharmaceuticals (MIST) Income Statement

788 Followers

Milestone Pharmaceuticals Income Statement

Last quarter (Q4 2025), Milestone Pharmaceuticals's total revenue was $1.55M, an increase of Infinity% from the same quarter last year. In Q4, Milestone Pharmaceuticals's net income was $-17.41M. See Milestone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.55M$ 0.00$ 1.00M$ 5.00M$ 15.00M
Gross Profit
$ 1.43M$ 0.00$ 1.00M$ 5.00M$ 15.00M
Operating Expenses
$ 63.92M$ 42.10M$ 62.10M$ 64.64M$ 58.07M
Depreciation and Amortization
$ 114.00K$ 105.00K$ 92.00K$ 89.00K$ 93.00K
EBITDA
$ -62.14M$ -37.83M$ -57.04M$ -58.30M$ -42.98M
Operating Income
$ -62.48M$ -42.10M$ -61.10M$ -59.64M$ -43.07M
Other Income/Expenses
$ -918.00K$ 583.00K$ 1.41M$ 1.25M$ 220.00K
Pretax Income
$ -63.40M$ -41.52M$ -59.69M$ -58.39M$ -42.85M
Net Income
$ -63.06M$ -41.52M$ -59.69M$ -58.39M$ -42.85M
Per Share Metrics
Basic EPS
$ -0.75$ -0.67$ -1.39$ -1.35$ -1.02
Diluted EPS
$ -0.75$ -0.67$ -1.39$ -1.35$ -1.02
Weighted Average Shares Outstanding
 83.88M 62.21M 42.96M 42.45M 41.83M
Weighted Average Shares Outstanding (Diluted)
 83.88M 62.21M 42.96M 42.45M 41.83M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History